Trial intelligence / Profile preview

Rivaroxaban Phase 3 Trial in Japan

jRCT2080222519Phase 3Completed

Start
Jun 2014
Modality
Small Molecules
01

Overview

Phase 3 trial of rivaroxaban. Started Jun 2014; status: completed.

02

Drugs

rivaroxaban

Beyond the preview

Go deeper on jRCT2080222519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call